The apheresis program began in 1991 and performs leukapheresis (removal of white blood cells), plasmapheresis (removal of plasma) and erythrocytapheresis (removal of red blood cells). 

Leukapheresis 

Three types of leukapheresis procedures are performed. The most common type is hematopoietic peripheral blood stem cell (PBSC) collection (autologous and allogenic). Bone marrow processing and white blood cell (WBC) depletion are also performed. Download pamphlet on Peripheral Blood Stem Cell Collection

Erythrocytapheresis

The process of removing red blood cells in circulation and replacing it with donor red blood cells is known as red cell exchange. Download pamphlet on Red Cell Exchange

Plasmapheresis

Plasma Exchange or "Plex" as it is sometimes referred to is commonly used to treat autoimmune or immune-mediated diseases and disorders. In most cases, 4-6 treatments are required to achieve a response. Plasma exchange removes circulating plasma components such as immunoglobulins, albumin, fibrinogen and other clotting factors, urea, creatinine, and electrolytes. It can also remove alloantibodies, autoimmune antibodies, antigen-antibody complexes, plasma proteins, metabolic waste products and plasma-bound drugs or poisons. These antibodies can attack healthy cells or tissue. Other diseases can cause too much protein to be made, which can slow down the blood flow. Some diseases/illnesses such as Myasthenia gravis, Guillain-Barre, acute disseminated encephalomyelitis, Goodpasture's and Wegener's syndrome, thrombotic thrombocytopenic purpura, atypical hemolytic-uremic syndrome, autoimmune hemolytic anemia, and sepsis with multi-organ failure are treated with Plex. Download pamphlet on Plasma Exchange